DLA Piper wins M&A Advisor Healthcare/Life Sciences Deal of the Year award
DLA Piper has been awarded the M&A Advisor Healthcare/Life Sciences Deal of the Year (under $250m or £160m) for its representation of Synergy Health in its private acquisition of SRI/Surgical Express Inc.
Synergy Health is known for its work in outsourced sterilisation services to the medical device market, hospitals and other global healthcare providers.
The DLA Piper team that led the acquisition consisted of Joshua Kaye (Miami), Adam Rogers (Miami) Jonathan Klein (New York) and Tristram Cleminson (New York), with support from Gina Zawitoski (Baltimore), Amy Beckstead (Austin), Paolo Pasicolan (Washington DC), Dale Lazar (Reston), Ryan Compton (Washington DC), Mike Bedke (Tampa), Stephanie Kane (Tampa), Dawn Stern (Washington DC) and Richard Rector (Washington DC), among others.
DLA Piper also won the M&A Advisor M&A Deal of the Year (between $10m and $50m) award for its role in the acquisition of Eclipse Therapeutics by Bionomics, as well as the Corporate/Strategic Acquisition of the Year (over $50m to $100m) award for the sale of Trident Microsystems.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
China’s State Administration of Taxation actively advances the Base Erosion and Profit Shifting 2014 Deliverables
In September 2014, SAT released a Chinese translation of the G20/OECD BEPS 2014 Deliverables. This was followed by a conference discussion between SAT and taxpayers.
It is clear that the Renewable Energy Act has succeeded in attracting more investment in solar PV than Japan’s grid can handle.
Analysis from The Lawyer
Regulators are ramping up the pressure in the aftermath of recession, leaving firms to compete for compliance and restructuring work
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.